Univar Solutions Expands Pharmaceutical Ingredients Portfolio Through New Distribution Agreement with SI Group
Univar Solutions Brasil, a subsidiary of Univar Solutions, a leading global solutions provider to users of specialty ingredients and chemicals, today announced a distribution agreement with SI Group for Ibuprofen, an active pharmaceutical ingredient (API) used to produce ibuprofen drugs for the pharmaceutical market.
“Our strategic relationship with SI Group provides customers in Brazil access to a robust portfolio of innovative specialty ingredients and supply products in significant demand in the Brazilian market. We’re proud to team up with a supplier who is also passionate about working at the intersection of science and technology to deliver products that help keep communities healthy and safe,” said James Peterson, global vice president of pharmaceutical ingredients for Univar Solutions.
“Univar Solutions proudly serves pharmaceutical manufacturers and formulators focused on delivering advanced, science-based pharmaceutical solutions, offering the ingredients they seek for critically important health care products,” said Jorge Buckup, president of Latin America for Univar Solutions. “Together with SI Group, we’re better able to help customers formulate next-generation products, work to improve time to market, and achieve sustainable solutions through ingredients and innovations.”
“SI Group is thrilled to grow our partnership with Univar Solutions, a global leader in ingredient and specialty distribution with deep expertise and a reliable, resilient network and supply chain solutions,” said Cathryn D. Estes, senior director of pharmaceuticals and global distribution for SI Group. “Together, we can leverage our ingredients and services and bring our Brazilian customers the ingredients and products they need to grow and serve their markets.”
With the recent increase in demand for over-the-counter analgesics, the addition of Ibuprofen to Univar Solutions’ ingredients portfolio in Brazil will provide pharmaceutical manufacturers with an important source of supply. Combined with a team of industry experts, a global network of pharmaceutical compliant facilities, and Solution Centers staffed by technical experts, Univar Solutions offers pharmaceutical and biopharmaceutical customers and suppliers support for their pharmaceutical, ophthalmic, nutraceutical, biopharma, animal health and medical device applications.
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more